Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01691430 · ClinicalTrials.gov registry record · Phase 3
A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents
A Phase 3 study of Bacteriuria, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 185
- Enrollment target
- 20
- Study locations
NCT01691430 is a Phase 3 study of Bacteriuria that has completed, run by Yale University. The registered enrollment target is 185 participants. The trial reports 20 study locations across 1 state.
The verdict
NCT01691430, a Phase 3 study of Bacteriuria, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 185 participants
- Enrollment target
- 20
- Study locations
Study Summary
Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 2 cranberry capsules
Study Locations (20)
Connecticut
- Branford Hills Health Care - Branford
- Northbridge Health Care Center - Bridgeport
- Bridgeport Health Care Center - Bridgeport
- Bridgeport Manor - Bridgeport
- Riverside Health & Rehabilitation Center - East Hartford
- Ludlowe Health Care Center - Fairfield
- Glastonbury Health Care Center - Glastonbury
- The Nathaniel Witherell - Greenwich
- Arden House Care and Rehabilitation Center - Hamden
- Hamden Health Care Center - Hamden
- Avery Heights - Hartford
- Wadsworth Glen Health Care and Rehabilitation Center - Middletown
- Water's Edge Center for Health & Rehabilitation - Middletown
- Grimes Center - New Haven
- Mary Wade Home - New Haven
- Advanced Nursing & Rehab Center of New Haven - New Haven
- Shady Knoll Health Center - Seymour
- Lord Chamberlain Nursing & Rehabilitation Center - Stratford
- Village Green of Wallingford - Wallingford
- Abbott Terrace Health Center - Waterbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01691430
The ClinicalTrials.gov registry entry for NCT01691430 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacteriuria appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01691430 reports 20 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01691430 about?
NCT01691430 is a clinical study titled "A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents". Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacter...
What is the current status of trial NCT01691430?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 185 participants. The study started on 2012-08. Estimated completion is 2015-10.
What conditions does trial NCT01691430 study?
This clinical trial studies the following conditions: Bacteriuria.
What interventions are being tested in trial NCT01691430?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 2 cranberry capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01691430?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01691430 being conducted?
This trial has 20 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteriuria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.